Millennium Management’s Akcea Therapeutics Inc AKCA Stock Holding History

Millennium Management’s Portfolio AKCA Stock Details AKCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-16,219	Closed	-$294	–	5858
2020 Q3	$294	Buy	+16,219	New	+$230K	﹤0.01%	3856
2020 Q2	–	Sell	-84,871	Closed	-$1.21M	–	4838
2020 Q1	$1.21M	Buy	84,871 +2,225	+3%	+$36.5K	﹤0.01%	2347
2019 Q4	$1.4M	Buy	+82,646	New	+$1.54M	﹤0.01%	2823
2019 Q3	–	Sell	-14,142	Closed	-$332K	–	4729
2019 Q2	$332K	Buy	+14,142	New	+$349K	﹤0.01%	3489
2018 Q3	–	Sell	-63,998	Closed	-$1.52M	–	4458
2018 Q2	$1.52M	Buy	63,998 +51,894	+429%	+$1.24M	﹤0.01%	2587
2018 Q1	$310K	Buy	+12,104	New	+$261K	﹤0.01%	3202

Millennium Management's AKCA Position: Q4 2020 in Review

Millennium Management sold out of Akcea Therapeutics Inc (AKCA) in Q4 2020, closing a stake of 16,219 shares — an estimated $294 sold.

Millennium Management first reported a position in AKCA in Q1 2018 and held it in 6 quarters. The position peaked at $1.52M in Q2 2018. 0 funds tracked by Wall St. Rank hold AKCA as of Q4 2020.

Millennium Management reported no remaining Akcea Therapeutics Inc position as of Q4 2020 after selling out during the quarter.
Millennium Management sold 16,219 Akcea Therapeutics Inc shares in Q4 2020, an estimated $294.
Millennium Management first reported a position in Akcea Therapeutics Inc in Q1 2018 and held it in 6 quarters.
Millennium Management's Akcea Therapeutics Inc position peaked at $1.52M in Q2 2018.
0 funds tracked by Wall St. Rank held Akcea Therapeutics Inc as of Q4 2020.

Based on Millennium Management's 13F filing for Q4 2020, filed 16 Feb 2021.